tirzepatide egfr cut-off Not all GLP-1 receptor agonists may affect kidney health the same Correlation between changes in eGFR

It is possible that this relatively selective colonic mucosal involvement may reflect the qualitative or quantitative differences in colonic microbial flora (as opposed to the small intestine)

7 , e12139 (2021)

Last Updated On 24 Jul

These include: Bloating and gas : Increased bacterial fermentation produces gases, causing abdominal distension and flatulence Mild abdominal discomfort or cramping : Usually resolves as the microbiome stabilises Changes in bowel habits : Temporary loose stools or, less commonly, constipation Nausea : Occasionally reported, particularly if taken on an empty stomach These symptoms typically diminish within 23 weeks of consistent use